Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 5/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.30 |
| ▸ | FNTB | P49356 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20482614 | 1.00 | CXCR4 (0.39) | CXCR4CYP2D6NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL11853601 | 0.98 | CXCR4 (0.38) | CXCR4CYP2D6NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL11854967 | 0.98 | CXCR4 (0.38) | CXCR4CYP2D6NOS3NOS1NOS2 | |
| SCHEMBL12983640 | 0.89 | NOS3 (0.35) | CXCR4NOS3NOS1NOS2FNTA | |
| SCHEMBL6845123 | 0.89 | NOS3 (0.35) | CXCR4NOS3NOS1NOS2FNTA | |
| SCHEMBL12346329 | 0.81 | CXCR4 (0.37) | CXCR4CYP2D6NOS3NOS1NOS2 | |
| SCHEMBL20851571 | 0.81 | CXCR4 (0.37) | CXCR4CYP2D6NOS3NOS1NOS2 | |
| SCHEMBL1688215 | 0.81 | CXCR4 (0.37) | CXCR4CYP2D6NOS3NOS1NOS2 | |
| SCHEMBL4066382 | 0.80 | DRD2 (0.40) | ACHE | |
| SCHEMBL11522496 | 0.79 | CXCR4 (0.36) | CXCR4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12582645-B2 | Chemokine CXCR4 receptor modulators and uses related thereto | EMORY UNIVERSITY (US) | 2026-03-24 | — | — | US | disclosed |
| US-20240316034-A1 | Chemokine CXCR4 Receptor Modulators and Uses Related Thereto | UNIV EMORY (US) | 2024-09-26 | — | — | US | disclosed |
| US-20230112832-A1 | Chemokine CXCR4 Receptor Modulators and Uses Related Thereto | UNIV EMORY (US) | 2023-04-13 | — | — | US | disclosed |
| US-11497744-B2 | Chemokine CXCR4 receptor modulators and uses related thereto | EMORY UNIVERSITY (US) | 2022-11-15 | — | — | US | disclosed |
| US-20200054623-A1 | Chemokine CXCR4 Receptor Modulators and Uses Related Thereto | EMORY UNIVERSITY | 2020-02-20 | — | — | US | disclosed |
| CN-110545814-A | Chemokine CXCR4 receptor modulators and uses related thereto | UNIV EMORY | 2019-12-06 | — | — | CN | disclosed |
| WO-2018156595-A1 | CHEMOKINE CXCR4 RECEPTOR MODULATORS AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2018-08-30 | — | — | WO | disclosed |
| US-20040127361-A1 | Pyridinyl fused bicyclic amides as fungicides | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-07-01 | — | — | US | disclosed |
| EP-1387612-A1 | PYRIDINYL FUSED BICYCLIC AMIDE AS FUNGICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-02-11 | — | — | EP | disclosed |
| WO-2002091830-A1 | PYRIDINYL FUSED BICYCLIC AMIDE AS FUNGICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-11-21 | — | — | WO | disclosed |
| US-5001131-A | Pyridine derivatives | JOHN WYETH & BROTHER LIMITED (GB) | 1991-03-19 | — | — | US | disclosed |
| US-3991065-A | ANTIULCER AGENTS, CHEMICAL INTERMEDIATES | JOHN WYETH & BROTHER LIMITED (EN) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200054623-A1 | Chemokine CXCR4 Receptor Modulators and Uses Related Thereto | CXCR4, CXCL12, CXCR1 | CXCR4 1/4885CYP2D6 4404/4885NOS3 2540/4885 |
| US-20240316034-A1 | Chemokine CXCR4 Receptor Modulators and Uses Related Thereto | CXCR4, CXCL12, CXCR1 | CXCR4 1/4885CYP2D6 4404/4885NOS3 2540/4885 |
| US-11497744-B2 | Chemokine CXCR4 receptor modulators and uses related thereto | CXCR4, CXCL12, CXCR1 | CXCR4 1/4885CYP2D6 4404/4885NOS3 2540/4885 |
| US-20040127361-A1 | Pyridinyl fused bicyclic amides as fungicides | CBR3, CBR1, CNPY2 | CXCR4 3482/4885CYP2D6 54/4885NOS3 214/4885 |
| US-20230112832-A1 | Chemokine CXCR4 Receptor Modulators and Uses Related Thereto | CXCR4, CXCL12, CXCR1 | CXCR4 1/4885CYP2D6 4404/4885NOS3 2540/4885 |
| US-12582645-B2 | Chemokine CXCR4 receptor modulators and uses related thereto | CXCR4, CXCR2, CXCR1 | CXCR4 1/4885CYP2D6 3214/4885NOS3 2683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.